Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Smartphone-derived digital motor measures to monitor progression in idiopathic REM sleep behavior disorder.

NPJ Parkinson's disease·2026
Same author

SPIRIT 2025 statement: updated guideline for protocols of randomised trials.

Lancet (London, England)·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Cognitive profiles at presentation and subsequent cognitive decline and quality of life in Parkinson's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Aligning SPIRIT and SAGER guidelines for equity in clinical trials - Authors' reply.

Lancet (London, England)·2025
Same author

The relation of eye movements to the occurrence of freezing of gait in Parkinson's disease.

Brain communications·2025

関連する実験動画

Updated: Jul 6, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

確率比を用いた臨床診断の精細化

David A Grimes1, Kenneth F Schulz

  • 1Family Health International, PO Box 13950, Research Triangle Park, NC 27709, USA. dgrimes@fhi.org

Lancet (London, England)
|April 27, 2005
PubMed
まとめ

確率比は,病気と健康な個人の検査結果を比較することによって,臨床診断を強化します. これらの比率は,未充分に利用されているものの,臨床評価と組み合わせると,診断の精度を大幅に改善します.

科学分野:

  • 医療診断 医療診断
  • 臨床的意思決定について

背景:

  • 確率比 (LRs) は,徴候と症状に基づいて臨床診断を洗練するための貴重なツールです.
  • その有用性にもかかわらず,LRは現在,患者のケアにおいて十分に活用されていない.
  • LRは,特定の結果を持つ病気患者の比率と,同じ結果を持つ健康な患者の比率を比較することによって,テストの診断値を定量化します.

研究 の 目的:

  • 臨床診断における確率比の重要性と適用を強調する.
  • 確率比が診断の精度を向上させる方法を強調する.

主な方法:

  • 二分法および多層テストの確率比計算の説明.
  • 確率比がテスト前からテスト後の確率シフトにどのように影響するかについての議論.

主要な成果:

  • 高い確率比は,検査結果が病気の個人により一般的であることを示している.
  • 低い確率比は,検査結果が健康な個人に多く見られることを示している.
  • 1に近い確率比は,診断確率に最小限の影響を及ぼします.

結論:

  • 確率比,特に高いか低い確率比は,臨床医の病気の確率推定を大幅に変えることができます.

さらに関連する動画

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection
10:02

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection

Published on: December 19, 2025

関連する実験動画

Last Updated: Jul 6, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection
10:02

Standardized SDS-PAGE Workflow for Personalized Protein Corona Profiling in Early Cancer Detection

Published on: December 19, 2025

  • 準検査からの確率比を正確な臨床診断と統合することで,総合的な診断の正確性が相乗的に向上します.